the HeraBEATs are all out in the field as much as in use in the hospital. There was a screen that was split into 24 or so little charts of currently active users... so at maybe 2:30pm or so AEDST there were at least 24 mums scanning their babies heart rates at the same time which is just amazing to watch happen. The more amazing bit was all of the BP and Blood sugar readings etc that kept going off, hundreds of users all through the day measuring blood pressure, blood sugar, weight, answering mental health questionnaires etc all just recording back into HeraCARE and any anomalies being highlighted for further review etc. really eye opening stuff, I'm pretty sure that HMD is working on a video with all of that sort of stuff on it. They have a couple of test HeraBEATs and accompanying accounts which you can click on and see all of the data, the real units weren't available for me to see any greater detail due to privacy etc but even looking through the data inputs of the test units was a great exercise in getting an understanding of the platform in action. Really user friendly and really functional.
The 22,000,000 C-notes aren't all getting sold so I think that's a bit of an extension of truth to say that's why the price is so depressed. The main reason I think is that the whole market is getting hammered by major macro events like wars, elections, stagflation etc... lots of reasons to sit on cash or move to unlisted places. Lots of smaller issues that still overwhelm poor little HMD... RHC in a takeover, Mayo and Sheba still not releasing important info, Mednax only using the licenses for low-risk pregnancies in 2 sites. To clarify that Mednax bit, they are actively working with HMD to make sure that the device and platform will be able to be fully compliant for use with High Risk, which is also what Sheba is looking into but not yet releasing reports of... Now if Sheba and Mayo et al all come back and validate the high risk bit then it allows Mednax to move faster on that part of the equation which in turn is a massive win for HMD. If RHC CFO allows an extension to the deal's number of licenses then thats another win, these aren't pie in the sky dreams of a lunatic fancy, these are very real outcomes that sit just that bit too far from HMD to raise the current appeal.
Dunno mate... things look about as good as they could from this point except that every thing in sight is also behind a glass wall. Kind of like window shopping in the days before Sunday trading... the most exciting bit is that should HeraCARE slot into these hospital groups in a more meaningful way it would seem extremely difficult to replace so the economic moat would indeed be investment grade. there is still plenty of risk that it all might just crumple into oblivion and it fails for every pilot and no-one wants it.
to be completely honest, I haven't felt this much conviction AND confusion simultaneously about ANY investment that I've had. I'm 100 or zero percent right and both are asa likely as each other. Best part of ASX investing is that if you're 100% wrong it only hurts 50% as you get the CGT benefit for tax-loss... such a funny cathartic place is this HMD series of threads.. hahahahaha
HMD Price at posting:
14.0¢ Sentiment: Buy Disclosure: Held
(20min delay)